Nuclosina - (Omeprazole)

Omeprazole, the active ingredient in Nuclosina, is a proton pump inhibitor presented as a strength/form for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults and children.

GNH USA supplies Nuclosina as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related gastrointestinal conditions: - Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and promotes healing of the esophageal lining. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls excessive gastric acid production. - Helicobacter pylori eradication regimens: used in combination with antibiotics to improve eradication rates. - NSAID‑associated ulcer prevention: lowers ulcer risk in patients requiring long‑term NSAID therapy.

Omeprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually transient. - Nausea: occasional and mild. - Abdominal pain: mild discomfort. - Flatulence: occasional gas buildup. - Constipation: infrequent mild constipation.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis risk. - Acute interstitial nephritis: kidney inflammation. - Severe allergic reactions: rash, itching, swelling, or anaphylaxis. - Low magnesium levels: may cause muscle cramps or arrhythmias. - Fracture risk: long‑term use linked to reduced bone density. - Vitamin B12 deficiency: potential malabsorption with prolonged therapy.

When prescribing Omeprazole, clinicians should consider several safety aspects: - Assess renal function: adjust use in severe renal impairment. - Review concomitant medications: potential for drug‑drug interactions. - Monitor long‑term use: evaluate need for continued therapy after several months. - Pregnancy and lactation: weigh benefits against potential risks. - Elderly patients: start with the lowest effective dose. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Omeprazole can affect the pharmacokinetics of several co‑administered drugs.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, may increase cardiovascular risk. - Atazanavir: decreased absorption, compromising antiviral efficacy. - Methotrexate: increased serum levels, risk of toxicity.

Moderate Interactions (Monitor Closely): - Warfarin: potential alteration of INR values. - Phenytoin: may reduce serum concentrations. - Digoxin: possible increase in plasma levels. - Ketoconazole: reduced absorption, lowering antifungal effectiveness.